It's a phase 2 trial and it's a guarantee they'll have to do a phase 3. All that they need from this one is to show safety and some efficacy. Cut the expenses on this one and by the time it's finished we have the money, we will be widely known and we'll be highly known in the longhaulers community for the results of this trial. We can then fill a 500-1000 patient phase 3 fast.